Total Payments
$1,738
2024 Payments
$249.57
Companies
18
Transactions
89
Medicare Patients
1,147
Medicare Billing
$59,974
Payment Breakdown by Category
Food & Beverage$1,644 (94.6%)
Education$94.00 (5.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,644 | 88 | 94.6% |
| Education | $94.00 | 1 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $477.33 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $393.63 | 22 | $0 (2024) |
| GlaxoSmithKline, LLC. | $181.33 | 9 | $0 (2024) |
| Astellas Pharma US Inc | $180.88 | 5 | $0 (2023) |
| ABBVIE INC. | $100.86 | 7 | $0 (2024) |
| Lilly USA, LLC | $90.50 | 6 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $41.04 | 2 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $39.80 | 2 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $34.66 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.05 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $249.57 | 13 | AstraZeneca Pharmaceuticals LP ($91.59) |
| 2023 | $586.35 | 26 | AstraZeneca Pharmaceuticals LP ($181.64) |
| 2022 | $510.95 | 28 | Novo Nordisk Inc ($279.29) |
| 2021 | $390.81 | 22 | Astellas Pharma US Inc ($86.88) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Obesity | ||||||
| 07/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: RESPIRATORY | ||||||
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/28/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Oncology | ||||||
| 01/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Respiratory | ||||||
| 10/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: DIABETES | ||||||
| 10/24/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Diabetes | ||||||
| 09/19/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Respiratory | ||||||
| 08/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/20/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Diabetes | ||||||
| 06/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Diabetes | ||||||
| 05/22/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 583 | 1,038 | $115,687 | $30,732 |
| 2022 | 16 | 564 | 973 | $104,964 | $29,242 |
Total Patients
1,147
Total Services
2,011
Medicare Billing
$59,974
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 149 | 264 | $44,795 | $12,382 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 149 | $37,697 | $10,368 | 27.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $3,655 | $1,741 | 47.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 28 | 29 | $6,520 | $969.36 | 14.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $5,083 | $889.98 | 17.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 11 | 22 | $2,904 | $808.69 | 27.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 22 | 44 | $1,760 | $713.68 | 40.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $888.00 | $692.88 | 78.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 48 | 83 | $2,413 | $663.13 | 27.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 42 | 58 | $1,537 | $552.16 | 35.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 23 | 23 | $1,495 | $503.70 | 33.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 13 | 13 | $260.00 | $186.16 | 71.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 37 | 170 | $4,250 | $129.04 | 3.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 28 | 37 | $370.00 | $81.40 | 22.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 24 | $360.00 | $25.95 | 7.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 16 | 68 | $1,700 | $25.67 | 1.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 242 | $41,055 | $12,536 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 122 | $30,866 | $9,573 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $8,712 | $1,377 | 15.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $2,580 | $1,280 | 49.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 27 | 31 | $7,130 | $1,085 | 15.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 27 | 60 | $2,400 | $983.10 | 41.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 50 | 71 | $2,048 | $588.75 | 28.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $580.00 | $432.82 | 74.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 38 | 45 | $1,193 | $431.47 | 36.2% |
About Bridget Walters
Bridget Walters is a Family healthcare provider based in Ocilla, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1669880456.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bridget Walters has received a total of $1,738 in payments from pharmaceutical and medical device companies, with $249.57 received in 2024. These payments were reported across 89 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,644).
As a Medicare-enrolled provider, Walters has provided services to 1,147 Medicare beneficiaries, totaling 2,011 services with total Medicare billing of $59,974. Data is available for 2 years (2022–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Ocilla, GA
- Active Since 07/24/2014
- Last Updated 10/16/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669880456
Products in Payments
- Rybelsus (Drug) $250.89
- Ozempic (Drug) $226.44
- FARXIGA (Drug) $184.22
- BREZTRI (Drug) $182.87
- TRELEGY ELLIPTA (Drug) $114.10
- MYRBETRIQ (Drug) $86.88
- VRAYLAR (Drug) $69.73
- AREXVY (Drug) $67.23
- Kerendia (Drug) $41.04
- GEMTESA (Drug) $39.80
- MOUNJARO (Drug) $35.12
- JARDIANCE (Drug) $34.26
- TRINTELLIX (Drug) $29.05
- XARELTO (Drug) $28.91
- TRULICITY (Drug) $24.54
- RAYALDEE (Drug) $20.72
- Cologuard Collection Kit (Device) $19.46
- ENTRESTO (Drug) $19.28
- Otezla (Drug) $19.23
- ZEPBOUND (Drug) $17.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Ocilla
Mrs. Maci Merritt, Fnp-C, FNP-C
Family — Payments: $711.19
Family $711.19
Lauren Adams, Np-C, NP-C
Family — Payments: $521.70
Family $521.70
Candace Billotte, Fnp-Bc, FNP-BC
Family — Payments: $366.34
Family $366.34
Mrs. Catherine Bowen, Np-C, NP-C
Family — Payments: $188.37
Family $188.37
Jodi Willingham, Np-C, NP-C
Family — Payments: $175.65
Family $175.65